|
Market Closed -
Deutsche Boerse AG
09:25:02 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.6174 EUR | -0.39% |
|
+9.98% | +8.32% |
Company Valuation: CStone Pharmaceuticals
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,845 | 4,882 | 2,628 | 2,759 | 6,980 | 7,891 | - | - |
| Change | - | -37.77% | -46.18% | 4.99% | 153.01% | 13.05% | - | - |
| Enterprise Value (EV) 1 | 7,249 | 4,551 | 1,950 | 2,404 | 6,404 | 7,363 | 4,288 | 3,715 |
| Change | - | -37.22% | -57.15% | 23.28% | 166.37% | 14.98% | -41.76% | -13.37% |
| P/E | - | -5.32x | -7.11x | -30.9x | -15.3x | -370x | 7.37x | 44.9x |
| PBR | 6.63x | 10.9x | 5.7x | - | 10.7x | - | - | - |
| PEG | - | - | 0.1x | 0.4x | -0x | 3.9x | -0x | -0.5x |
| Capitalization / Revenue | 32.2x | 10.1x | 5.67x | 6.78x | 25.9x | 16.5x | 4.61x | 7.15x |
| EV / Revenue | 29.7x | 9.45x | 4.2x | 5.9x | 23.8x | 15.4x | 2.5x | 3.37x |
| EV / EBITDA | -3.99x | -5.1x | -3.33x | -25.9x | -16.5x | -18x | 2.19x | 5.13x |
| EV / EBIT | -3.96x | -4.99x | -3.22x | -22.7x | -14.8x | -19.2x | 3.83x | 20.9x |
| EV / FCF | -4.57x | -7.43x | - | - | -19.5x | 3,682x | 57.9x | 53.1x |
| FCF Yield | -21.9% | -13.5% | - | - | -5.12% | 0.03% | 1.73% | 1.88% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | -0.77 | -0.29 | -0.07 | -0.31 | -0.0133 | 0.67 | 0.11 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 243.7 | 481.4 | 463.8 | 407.2 | 269.6 | 479.3 | 1,713 | 1,103 |
| EBITDA 1 | -1,818 | -892.9 | -585.4 | -92.72 | -388.6 | -409.6 | 1,962 | 724.4 |
| EBIT 1 | -1,829 | -912.1 | -605.6 | -106.1 | -432.6 | -383.2 | 1,118 | 177.6 |
| Net income 1 | -1,920 | -902.7 | -367.2 | -91.21 | -437 | -243.2 | 687.4 | 93.49 |
| Net Debt 1 | -596.2 | -331.1 | -677.7 | -354.7 | -576.3 | -528.2 | -3,603 | -4,177 |
| Reference price 2 | 6.737 | 4.096 | 2.061 | 2.161 | 4.736 | 4.938 | 4.938 | 4.938 |
| Nbr of stocks (in thousands) | 1,164,452 | 1,192,099 | 1,275,317 | 1,276,503 | 1,473,942 | 1,598,209 | - | - |
| Announcement Date | 6/8/22 | 4/26/23 | 4/23/24 | 3/27/25 | 3/26/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 18.61x | 4.33x | 10.21x | 0.49% | 80.23B | |
| 37.7x | 12.88x | 24.51x | -.--% | 50.64B | |
| 21.26x | 4.7x | 13.43x | 0.69% | 46.87B | |
| -51.83x | 3.58x | 10.59x | 2.95% | 46.34B | |
| 37.28x | 3.45x | 13.12x | -.--% | 31B | |
| -7.38x | 10.27x | -6.63x | -.--% | 25.28B | |
| 52.93x | 3.38x | 26.22x | -.--% | 24.36B | |
| 69.87x | 6.7x | 44.75x | -.--% | 20.81B | |
| 23.08x | 4.97x | 12.94x | -.--% | 16.08B | |
| Average | 22.39x | 6.03x | 16.57x | 0.46% | 37.96B | |
| Weighted average by Cap. | 17.80x | 6.01x | 15.21x | 0.61% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
- Valuation CStone Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
